LON: REDX 96.55GBX

RXC004 Phase 1 monotherapy data to be presented at ESMO Congress 2021 Redx Pharma Announces Milestone Payment from Jazz Pharmaceuticals Redx Pharma Announces Phase 2 Dose Selection of its Porcupine Inhibitor, RXC004

About us
Our pipeline
Our science
- Our scientific publications
Investors
News & events
- News & events
Contact us
- Contact us
- Careers

About us
Our pipeline
Our science
- Our scientific publications
Investors
News & Events
- News & events
Contact
- Contact us
- Careers

Top suggestions

RXC004 Phase 1 monotherapy data to be presented at ESMO Congress 2021
Redx Pharma Announces Milestone Payment from Jazz Pharmaceuticals
Redx Pharma Announces Phase 2 Dose Selection of its Porcupine Inhibitor, RXC004

Email alerts

Investor centre

Presentations, analyst reports, documents & videos

Reports & Accounts

Contact us

RSS

Copyright © 2021 Redx Pharma Plc

Privacy policy
Cookie policy

Website design & build by Carr Kamasa Design

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies. Cookie Policy.